Valuation
- Market cap
- 1,878,718,000
- Revenue TTM
- $211,080,000
- Net income TTM
- $-51,060,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -24.19%
- Debt to equity
- 12.11
Trading
- Volume
- 309,200
- Avg volume
- 423,394
- Day's range
- $62.40 – $65.30
- Shares out
- 29,802,000
- Stochastic %K
- 22%
- Beta
- 1.06
- Analysts
- Strong Sell
- Price target
- $103.75
Company profile
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospi...
Show more
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 800 924 5072
- Website
- https://www.establishmentlabs.com
- Address
- 11401 century oaks terrace, suite 400, Austin, United States
Latest news
No headlines yet.
